Eton Pharmaceuticals Inc (ETON NASDAQ) stock market data APIs
$14.4208
0.13(0.9%)
as of July 14, 2025
Try our APIs with
free plan!
Eton Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
Prev. Close
14.4208
Open
14.5509
High
15.0322
Low
14.2519
52 wk Range
3.2519-21.48
Market Cap
389 M
Shares Outstanding
26 818 K
Revenue
48 327 K
EPS
-0.06
Beta
1.28
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eton Pharmaceuticals Inc data using free add-ons & libraries
Get Eton Pharmaceuticals Inc Fundamental Data
Eton Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 48 327 K
- EBITDA: 3 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-11
- EPS/Forecast: -0.02
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eton Pharmaceuticals Inc News
New
Adrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and Pfizer
Company Logo The global adrenal crisis market is witnessing significant growth driven by increasing adrenal insufficiency recognition and rising adrenal crisis incidents. The expanding global prevale...
FDA accepts Eton's NDA for ET-600 desmopressin oral solution
DEER PARK, Ill. - Eton Pharmaceuticals, Inc. (NASDAQ:ETON), a specialty pharmaceutical company with a market capitalization of $386 million and an impressive 323% return over the past year, announced ...
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)
- NDA assigned a Target Action Date of February 25, 2026 - - Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” o...
Sector Update: Health Care Stocks Mixed Friday Afternoon
Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index adding 0.1% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
